Journal of Blood Disorders & Transfusion

Expression of TIM-3 on plasmacytoid dendritic cells as a predictive biomarker of decline in HIV-1 RNA level during ART

Joint Event on Hematology, Immunology & Traditional Medicine

December 05-06, 2018 | Lisbon, Portugal

Albert Font Haro

Charles University, Czech Republic

Posters & Accepted Abstracts: J Blood Disord Transfus

Abstract:

HIV-1 infection is associated with functional impairment and depletion of plasmacytoid dendritic cells (pDCs). The mechanisms of disfunction of pDCs are still unknown. Here, we investigated the development of phenotype of pDCs in a cohort of 21 HIV-1 infected individuals before treatment and during 9 months since the start of antiretroviral therapy (ART). With the aid of polychromatic flow cytometry we detected a higher expression of HIV-1 receptor CD4, as well as of the regulatory receptor BDCA-2, the marker of killer pDC TRAIL, the Fc? receptor CD32, and the surface protein TIM-3 in treatment-na�ve individuals compared to healthy controls. After 9 months of treatment the level of expression of these markers approached but not reached the expression levels observed in healthy donors. We found a negative correlation between the expression of TIM-3 and the rate of decline of HIV-1 RNA level over the first 3 months of ART. We concluded that pDC immunogenic phenotype is not completely restored after 9 months of sustained suppression of HIV-1 RNA levels in ART-treated individuals and that the level of TIM-3 surface expression on pDCs in treatment-na�ve patients could be a predictive marker of the rate of decline in HIV-1 RNA level during ART.

Biography :

Albert Font Haro is a PhD student at the age of 32 years Charles University in Prague, Czech Republic. He has published 3 papers in reputed journals.

E-mail: afont.haro@gmail.com